How to appeal your Humana experimental or investigational denial
Carriers commonly deny coverage by labeling a treatment 'experimental' or 'investigational', a designation that bypasses the usual medical-necessity analysis. This guide is specific to Humana appeals.
Why Humana denies experimental or investigational
Humana is among the top three Medicare Advantage carriers and also operates Tricare and a smaller commercial book. Medicare Advantage prior auth is the highest-volume denial category.
For experimental or investigational specifically: Carriers commonly deny coverage by labeling a treatment 'experimental' or 'investigational', a designation that bypasses the usual medical-necessity analysis. These denials are appealable, and many reverse when peer-reviewed evidence, compendia listings, or clinical-trial data are presented.
FDA approval for the indication, recognized compendia (NCCN, AHFS-DI, DrugDex), and CMS National Coverage Determinations defeat an 'experimental or investigational' label.
What Humana denies for experimental or investigational
The experimental or investigational services most often denied:
- Off-label oncology regimens
- Newer CAR-T and cellular therapies
- Proton beam therapy
- Genetic and biomarker testing (next-generation sequencing)
- Surgical techniques deemed novel
- Compassionate-use and expanded-access drugs
Why experimental or investigational claims get denied
A typical Humana experimental or investigational denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Treatment is not specifically FDA-approved for the indication
- Plan policy bulletin lists the service as investigational
- No randomized controlled trial cited in plan's policy
- Service is not in a recognized compendium for the diagnosis
The Humana appeal process
Appeal levels: Medicare Advantage federal 5-level ladder. Commercial: internal then external review.
Carrier timing: Medicare Advantage: 60 days between each level. Commercial: 180 days from denial for internal, 60 days for external.
Experimental timing: Internal appeal: 180 days from denial. External review: typically 4 months / 120 days from final internal denial. Expedited urgent review: 72 hours.
What we know about Humana: Humana cases benefit most from level-2 (Maximus) escalation. We don't stop at level 1.
Common Humana denial patterns for experimental or investigational
- Five-level Medicare appeal process. Humana Medicare Advantage denials enter the federal appeal ladder: plan reconsideration → IRE (Maximus) → ALJ → Medicare Appeals Council → federal court. Federal data show Medicare Advantage plans overturn a large share of denials once they are appealed, yet very few members appeal; reversal odds stay meaningful through the IRE and ALJ levels.
- DME (durable medical equipment) denials. Humana DME denials often cite missing home-evaluation documentation. Re-filing with the home-evaluation packet attached is the most common reversal path.
- Skilled nursing and post-acute care. Humana has been the subject of CMS audits on early termination of skilled nursing coverage. Appeals citing CMS coverage manual standards have a documented success record.
How to win your Humana experimental or investigational appeal
Strategy for experimental or investigational: Identify the plan's exact 'experimental/investigational' policy bulletin and rebut it point-by-point. Cite NCCN, ASCO, AHFS-DI, DrugDex, or other recognized compendia for the indication. Attach peer-reviewed literature and any clinical-trial enrollment data. Many state external review programs apply a heightened standard for E/I denials, once the case reaches external review, the IRO physician panel often overturns.
Filed against Humana, that strategy rides on this procedural spine:
- Procedural-rights anchor. Every Humana denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
- Criteria-disclosure demand. Humana frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. FDA approval for the indication, recognized compendia (NCCN, AHFS-DI, DrugDex), and CMS National Coverage Determinations defeat an 'experimental or investigational' label.
- Treating-provider attestation. A letter from the treating physician addressing each criterion in Humana's own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the experimental or investigational denial and approve the service, not a general "please reconsider."
Documents you'll need for your Humana experimental or investigational appeal
- Denial letter (with plan's E/I policy bulletin)
- Treating physician's letter of medical necessity
- Peer-reviewed literature supporting the therapy
- Compendium entry (NCCN, ASCO, AHFS-DI, DrugDex)
- Pathology / diagnostic report
What a experimental or investigational appeal can recover
Typical recovery for experimental or investigational cases runs $5,000 - $500,000+ depending on therapy. The exact figure depends on the specific service and your plan's contracted rates.
Humana experimental or investigational appeals: frequently asked questions
Can I appeal an 'experimental or investigational' denial from Humana?
Yes, and these reverse often at external review. Identify the plan's exact experimental/investigational policy bulletin and rebut it point by point with FDA approval for the indication, recognized compendia, and peer-reviewed evidence.
What beats an 'experimental' label?
FDA approval for the specific indication, a recognized compendium entry (NCCN, AHFS-DI, DrugDex), a CMS national coverage determination, and peer-reviewed literature. Many state external-review programs apply a heightened standard for these denials.
How long do I have for an experimental-denial appeal?
Internal appeals are due within 180 days. External review is typically available within 4 months (120 days) of the final internal denial, and urgent cases qualify for 72-hour expedited review.
Why does Humana call a standard treatment experimental?
Usually because the therapy is not specifically FDA-approved for that indication, the plan's bulletin lists it as investigational, or no randomized trial is cited in the policy. A compendium entry for your diagnosis directly contradicts that classification.
What Apellica does for Humana experimental or investigational appeals
We file appeals against Humana specifically configured to its internal review process. Every experimental or investigational appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for Humana appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your Humana experimental or investigational appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Related Humana guides
- Humana surgery denials appeal guide
- Humana mri and imaging denials appeal guide
- Humana medication and prescription denials appeal guide
- Humana medicare denials appeal guide